A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or   in combination with nivolumab (NIVO) +/- linrodostat mesylate, followed   by adjuvant postsurgical NIVO +/- linrodostat, in cisplatin-eligible   muscle invasive bladder cancer (MIBC).

Title:: A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) +/- linrodostat mesylate, followed by adjuvant postsurgical NIVO +/- linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).
Document type:: Meeting Abstract
Author(s):: Sonpavde, Guru; Necchi, Andrea; Gupta, Shilpa; Steinberg, Gary D.; Gschwend, Juergen; Van der Heijden, Michiel Simon; Richiero, Audrey; Lambert, Alexandre; Raybold, Bradley; Gajavelli, Srikanth; Zardavas, Dimitrios; Galsky, Matt D.
Journal title abbreviation:: J Clin Oncol
Year:: 2020
Journal volume:: 38 Suppl S
Journal issue:: 15
Print-ISSN:: 0732-183X
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: